Procurement Summary
Country: USA
Summary: Dow Multiple Sclerosis Investigator-Initiated Research Award
Deadline: 13 Aug 2026
Posting Date: 06 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140728132
Document Ref. No.: HT942526MSRPIIRA
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Summary: The Fiscal Year 2026 (Fy26) Multiple Sclerosis Research Program (Msrp) Investigator-Initiated Research Award (Iira) Supports Highly Rigorous, High-Impact Research Projects That Have The Potential To Make An Important Contribution To Multiple Sclerosis (Ms) Research, Patient Care, And/Or Quality Of Life. All Applications Must Address At Least One Of The Fy26 Msrp Iira Focus Areas. Research Projects May Focus On Any Phase Of Research, Excluding Clinical Trials. The Rationale For A Research Idea May Be Derived From Laboratory Discovery, Clinical Trial Results, Population-Based Studies, A Clinician-S Firsthand Knowledge Of Patients, Or Anecdotal Data. Applications Must Include Preliminary And/Or Published Data That Are Relevant To Ms And The Proposed Research Project.Distinctive Features: This Funding Mechanism Includes Two Options: Established Investigator Or New Investigator. The New Investigator Option Supports Applicants Early In Their Faculty Appointments.Eligibilityeligible Applicantsmiscellaneousunrestrictedadditional Informationgrantor Contact Informationdescriptionebrap Help Desk Phone: 301-682-5507 Email: [email protected] Help Deskdocumentsfile Namedescriptionlast Updatedfy26 Msrp Iira Program Announcementmay 5, 2026 02:07 Pm Utclink To Additional Information--Closing: August 13, 2026
Posted Date: 2026-05-05 00:00:00
Funding instrument type: Grant
Documents
Tender Notice